2 reports

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.
  • Aurigene Discovery Technologies Limited - Research and Development Overview
  • Drugs to Target Fab Pathway for Gram Negative Bacterial Infections

R& D Progress Research and Development Brief Product Description Drugs to Inhibit MALT-## for Oncology and Inflammation Drugs are under development for the treatment of cancer and inflammation.

  • Oncology
  • Research And Development
  • World
  • Company Operations
  • Aurigene Discovery Technologies Limited